Cargando…

Comment on Liberski, Gajos, Sikorska, and Lindenbaum: “Kuru, the First Human Prion Disease” Viruses 2019, 11, 232

Detalles Bibliográficos
Autor principal:	Arens, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150943/ https://www.ncbi.nlm.nih.gov/pubmed/32150831 http://dx.doi.org/10.3390/v12030284

Ejemplares similares

Der Lindenbaum
por: Schubert, Franz, 1797-1828
Publicado: (1996)

Kuru, the First Human Prion Disease †
por: Liberski, Paweł P., et al.
Publicado: (2019)

El gajo de enebro : tragedia en tres actos
por: Mallea, Eduardo, 1903-1982
Publicado: (1957)

The origin of the prion agent of kuru: molecular and biological strain typing
por: Wadsworth, Jonathan D.F., et al.
Publicado: (2008)

The work of the Kuru Field Unit, Kuru Research Project of the Papua New Guinea Institute of Medical Research and MRC Prion Unit
por: Pako, Wandagi H.
Publicado: (2008)

Comments on Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Foster, Keith, et al.
Publicado: (2020)

Kuru
por: CERN. Geneva. Experimental Physics (EP) division
Publicado: (-)

Reflections on kuru
por: Prusiner, Stanley B.
Publicado: (2008)

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: Alberts, Pēteris
Publicado: (2020)

Richard Hornabrook's first impressions of kuru and Okapa
por: Beasley, Annette
Publicado: (2008)

Comment on Billant et al. p53, A Victim of the Prion Fashion. Cancers 2021, 13, 269
por: Liebman, Susan W., et al.
Publicado: (2023)

Comment on: “Search and Selection of Probiotics that Improve Mucositis Symptoms in Oncologic Patients: A Systematic Review. Nutrients 2019, 11, 2322”
por: de Simone, Claudio
Publicado: (2020)

My kuru adventure
por: Stöcklin, Werner H.
Publicado: (2008)

Some recollections about kuru in a patient at Rabaul in 1978, and subsequent experiences with prion diseases
por: Scrimgeour, Euan M.
Publicado: (2008)

Kuru likened to scrapie: the story remembered
por: Hadlow, William J.
Publicado: (2008)

Utility of Unrefined Carbohydrates in Type 2 Diabetes. Comment on “Reversing Type 2 Diabetes: A Narrative Review of the Evidence, Nutrients, 2019, 11, 766”
por: Joshi, Shivam, et al.
Publicado: (2019)

Comment on: Malfitano, A.M. et al. “Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Alberts, Pēteris
Publicado: (2020)

Reliable Measures of Sarcopenia in Cirrhosis. Comment on: “The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097”
por: Ebadi, Maryam, et al.
Publicado: (2020)

Dubious Claims about Simplicity and Likelihood: Comment on Pinna and Conti (2019)
por: van der Helm, Peter A.
Publicado: (2020)

Kuru and its contribution to medicine
por: Gajdusek, D. Carleton
Publicado: (2008)

My ‘brush’ with kuru research
por: Zu Rhein, Gabriele M.
Publicado: (2008)

Kuru: memories of the NIH years
por: Asher, David M.
Publicado: (2008)

Personal reflections on the neuropathology of kuru
por: Kakulas, Byron A.
Publicado: (2008)

Kuru fieldwork in 1981 … and beyond
por: Klitzman, Robert
Publicado: (2008)

Kuru memories from 1957
por: Scragg, Roy F.R.
Publicado: (2008)

Why Secondary Analyses in Vitamin D Clinical Trials Are Important and How to Improve Vitamin D Clinical Trial Outcome Analyses—A Comment on “Extra-Skeletal Effects of Vitamin D, Nutrients 2019, 11, 1460”
por: Grant, William B., et al.
Publicado: (2019)

Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51
por: Pontarollo, Giulia, et al.
Publicado: (2019)

Comment on “Enumeration of Escherichia coli in Probiotic Products. Microorganisms 2019, 7, 437”
por: Wassenaar, Trudy M., et al.
Publicado: (2020)

Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687
por: Aldinucci, Donatella, et al.
Publicado: (2020)

Sample Size Calculation. Comment on Quantitative Ultrasound and Dual X-Ray Absorptiometry as Indicators of Bone Mineral Density in Young Women and Nutritional Factors Affecting It, Nutrients, 2019, 11, 2336
por: Moran, Jose M., et al.
Publicado: (2019)

Editorial Comment on Firth et al. (2019)
por: Kop, Willem J., et al.
Publicado: (2020)

When is a Ketogenic Diet Ketogenic? Comment on “Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients, Nutrients 2019, 11, 1156”
por: Klement, Rainer Johannes
Publicado: (2019)

Comment on Chow, J.W.; Stokic, D.S. Longitudinal Changes in Temporospatial Gait Characteristics during the First Year Post-Stroke. Brain Sci. 2021, 11, 1648
por: Daly, Janis J.
Publicado: (2022)

Genetic susceptibility, evolution and the kuru epidemic
por: Mead, Simon, et al.
Publicado: (2008)

Mortuary rites of the South Fore and kuru
por: Whitfield, Jerome T., et al.
Publicado: (2008)

Understanding kuru: the contribution of anthropology and medicine
por: Lindenbaum, Shirley
Publicado: (2008)

Reminiscences and reflections on kuru, personal and scientific
por: Collinge, John, et al.
Publicado: (2008)

Early images of kuru and the people of Okapa
por: Gajdusek, D. Carleton
Publicado: (2008)

Reminiscences about kuru and the people of Okapa
por: Saweri, Adolf
Publicado: (2008)

The Adelaide Kuru Team in 1957–1959
por: Simpson, Donald A.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uiiqj0loniuhddl4ri2ngaop44